Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-23-080022
Filing Date
2023-07-11
Accepted
2023-07-11 17:09:41
Documents
3
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 PRE 14A tm2320771-1_pre14a.htm PRE 14A 2433596
2 GRAPHIC px_aceragen01page-4c.jpg GRAPHIC 732136
3 GRAPHIC px_aceragen02page-4c.jpg GRAPHIC 536600
  Complete submission text file 0001104659-23-080022.txt   4114008
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31918 | Film No.: 231082735
SIC: 2836 Biological Products, (No Diagnostic Substances)